These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16973833)

  • 1. In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33+90+45RA-.
    Vanheusden K; Van Coppernolle S; De Smedt M; Plum J; Vandekerckhove B
    Stem Cells; 2007 Jan; 25(1):107-14. PubMed ID: 16973833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional reversal within the early human hematopoietic compartment.
    Knaän-Shanzer S; van der Velde-van Dijke I; van de Watering MJ; de Leeuw PJ; Valerio D; van Bekkum DW; de Vries AA
    Stem Cells; 2008 Dec; 26(12):3210-7. PubMed ID: 18802041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
    Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
    Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells.
    Chan SL; Choi M; Wnendt S; Kraus M; Teng E; Leong HF; Merchav S
    Stem Cells; 2007 Feb; 25(2):529-36. PubMed ID: 17068185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection.
    Kimura T; Asada R; Wang J; Kimura T; Morioka M; Matsui K; Kobayashi K; Henmi K; Imai S; Kita M; Tsuji T; Sasaki Y; Ikehara S; Sonoda Y
    Stem Cells; 2007 Jun; 25(6):1348-55. PubMed ID: 17303816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells.
    McKenzie JL; Gan OI; Doedens M; Dick JE
    Exp Hematol; 2007 Sep; 35(9):1429-36. PubMed ID: 17656009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
    Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
    Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method.
    Yasutake M; Zheng Y; Inoue-Nagamura T; Akagawa E; Tokushima Y; Terashima S; Takahashi TA
    Transfusion; 2005 Dec; 45(12):1899-908. PubMed ID: 16371042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
    Mazurier F; Doedens M; Gan OI; Dick JE
    Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.
    Wong WM; Sigvardsson M; Åstrand-Grundström I; Hogge D; Larsson J; Qian H; Ekblom M
    Stem Cells; 2013 Feb; 31(2):360-71. PubMed ID: 23165626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells.
    Bruno S; Gunetti M; Gammaitoni L; Perissinotto E; Caione L; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Stem Cells; 2004; 22(2):135-43. PubMed ID: 14990853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential.
    Danet GH; Luongo JL; Butler G; Lu MM; Tenner AJ; Simon MC; Bonnet DA
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10441-5. PubMed ID: 12140365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.